Yiming (Beijing) Cell Biotechnology Co., Ltd. announced that it has raised $30 million in funding led by Goldstone Investment Group Limited and CLSA Capital Partners on September 27, 2022. THe transaction also includes participation from BGI Co-Win, Wenzhou Capital, Finnova Capital, IDG Capital Partners Co., Ltd. and Xingtou Capital, and existing investor Beijing FOF Capital Co.,Ltd., Huagai Capital Co., Ltd.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.024 HKD | -4.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 6.65M | |
+2.64% | 88.24B | |
+12.94% | 66.18B | |
+17.46% | 63.43B | |
+10.28% | 42.98B | |
+11.86% | 42.33B | |
+21.85% | 35.05B | |
+3.31% | 25.01B | |
-2.72% | 22.63B | |
+4.82% | 19.37B |
- Stock Market
- Equities
- 901 Stock
- News Goldstone Investment Group Limited
- Yiming Cell Biotechnology Co., Ltd. announced that it has received $30 million in funding from a group of investors